cover
Article Per Year (5 Year)
All
Home Page
OAI Link
Editorial Team
Contact
Reviewer
Google Scholar
Contact Name
Dwi Endah Kusumawati
Contact Email
dwiendahkusumawati@unissula.ac.id
Phone
+6285600056605
Journal Mail Official
ijmps@unissula.ac.id
Editorial Address
Jl. Kaligawe Raya No.KM, RW.4, Terboyo Kulon, Kec. Genuk, Kota Semarang, Jawa Tengah 50112 Indonesia
Location
Kota semarang,
Jawa tengah
INDONESIA
Indonesian Journal of Medical and Pharmaceutical Science
Published by Universitas Islam Sultan Agung
ISSN : -     EISSN : 28096576     DOI : -
Core Subject : Health, Science,
Chemistry Health Professions Immunology & microbiology Medicine & Pharmacology Public Health
This journal accepts and publishes academic articles focusing on theory, methods, and applications in: 1) Pharmaceutical science 2) Biomedical science 3) Herbal medicine 4) Clinical pharmacy 5) Drug discovery
Arjuna Subject : Pharmacology, Toxicology and Pharmaceutics - Pharmacology, Toxicology and Pharmaceutics (Lain-Lain)
Articles 52 Documents
 2   3   4   5   6 
Profil dan Efektivitas Terapi Pasien Glaukoma Rawat Jalan di Rumah Sakit di Yogyakarta Annisa, Lily; Jasmine, Iqtafit Zachrofati; Violita, Nindhi Happy
Indonesian Journal of Medical and Pharmaceutical Science Vol. 4 No. 2 (2025)
Publisher : Sultan Agung Islamic University of Semarang

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.30659/ijmps.v4i2.451

Abstract

Background: Glaukoma is one of the eye diseases that most often causes permanent blindness. The effectiveness of glaukoma therapy is generally assessed by the reduction of intraocular pressure and improvement of the patient's clinical condition. The research aims to examine the therapeutic profile and effectiveness of outpatient glaucoma patients in a hospital in Yogyakarta. Methods: This study is a descriptive observational study with a cross-sectional design. Data collection was carried out retrospectively through medical records of outpatients at hospitals in Yogyakarta in 2023-2024 with a purposive sampling method. Analysis of the relationship between treatment profiles and effectiveness was carried out using the Chi-square test. Results: In this study, patients with the use of antiglaukoma combination therapy regiments were more dominant (57.07%) with additional administration of supportive therapy of (71.73%). The combination of antiglaukoma groups of beta-blockers-prostaglandin analogs with the combination drug timolol-latanoprost was the most commonly administered drug (26.7%). Artificial tears (65.97%) are a supportive therapy often given in conjunction with antiglaukoma therapy. The analysis results showed there was no relationship between the therapy regiment (p = 0.41) or the type of therapy (p = 0.897) with the effectiveness of antiglaukoma drug therapy. Conclusion: Combination antiglaukoma therapy is given more often than monotherapy. The combination of timolol and latanoprost is the most commonly given regiment. The majority of patients received antiglaukoma along with supportive therapy. There was no relationship between the therapy regiment or the type of drug with the effectiveness of therapy.
Evaluasi Penggunaan Obat pada Pasien Rawat Inap Skizofrenia Paranoid di RSI Banjarnegara Tahun 2024 Kholid, Rofik; Dewi, Iva Rinia; Dewi, Hika Dwi Kartina
Indonesian Journal of Medical and Pharmaceutical Science Vol. 4 No. 2 (2025)
Publisher : Sultan Agung Islamic University of Semarang

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.30659/ijmps.v4i2.452

Abstract

Background: Paranoid schizophrenia, the most common form of schizophrenia characterized by delusions and hallucinations, is typically treated with antipsychotic medications. This research aimed to evaluate the medication use in 75 patients with paranoid schizophrenia at RSI Banjarnegara by adhering to the "5T" principles: correct diagnosis, patient, medication, dosage, and treatment duration. Methods: This study employed a descriptive observational approach. Retrospective data was collected by gathering medical records of paranoid schizophrenia patients admitted to the Inpatient Unit of RSI Banjarnegara throughout the year 2024. Results: The results show that the most widely used medication was Risperidone 2 mg, prescribed to 31 patients (41.3%). This was followed by Clozapine 25 mg, used by 20 patients (26.7%). The most common combination drug was Risperidone 2 mg and Clozapine 25 mg, administered to 7 patients (9.3%). Conclusion: The evaluation of drug use in paranoid schizophrenia patients demonstrated that all "5T" principles were met, with 100% correctness in diagnosis, patient identification, drug selection, dosage, and duration of administration.

Page 6 of 6 | Total Record : 52

 2   3   4   5   6 

Filter by Year

2022 2025


Reset
Filter By Issues
All Issue Vol. 4 No. 2 (2025) Vol. 4 No. 1 (2025) Vol. 3 No. 2 (2024) Vol. 3 No. 1 (2024) Vol. 2 No. 2 (2023) Vol. 2 No. 1 (2023) Vol. 1 No. 2 (2022) Vol. 1 No. 1 (2022)